Covid-19 vaccine update: Covaxin in 3rd phase of human trials, says ICMR director

By: |
Updated: Oct 27, 2020 9:44 PM

While the Covaxin has been approved to undergo the final phase of the human trials, the vaccine developed by Zydus Cadila and AstraZeneca are in the second phase of human trials, he said.

. Dr Bhargava said that it has well been established that pollution is contributing to Covid-19 mortality.. Dr Bhargava said that it has well been established that pollution is contributing to Covid-19 mortality.

In a significant development related to the Coronavirus vaccine, indigenous vaccine candidate – Covaxin – has got approval to conduct the third phase of clinical trials. The decision was announced by Dr Balram Bhargava, the Director General of the Indian Council of Medical Research (ICMR) , news agency ANI reported on Tuesday. Dr Bhargava also informed that three Coronavirus vaccine candidates are at different stages of clinical trials in the country. While the Covaxin has been approved to undergo the final phase of the human trials, the vaccine developed by Zydus Cadila and AstraZeneca are in the second phase of human trials, he said.

Covaxin, which is an indigenous vaccine candidate, has been developed by the Hyderabad-based Bharat Biotech and the Indian Council of Medical Research (ICMR). The human trials of the vaccine candidate developed by AstraZeneca and Oxford University are being conducted by the Serum Institute in India. Dr Bhargava said while the phase 2 human trials of the Cadila vaccine are going satisfactorily, that being conducted by the Serum Institute are also completing phase 2b human trials. He further said that the phase 3 human trials of the AstraZeneca vaccine candidate are also being conducted in other countries including Brazil, South Africa and the United States.

Meanwhile, in view of the increasing air pollution in the National Capital Region (NCR) and other North Indian cities, Dr Bhargava also said that on the basis of the studies conducted in Europe and the US, there seems to be a clear relation between the higher mortality and severe air pollution. Dr Bhargava said that it has well been established that pollution is contributing to Covid-19 mortality.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Kerala’s COVID-19 caseload almost touches 6 lakh mark; 5,643 new additions
2PM Modi to interact with 3 teams involved in developing COVID vaccine
3CII urges industry not to lower guard against COVID-19